Search

Things are certainly looking up in the market. The S&P 500 had an epic nine-day run of positive gains, the longest such streak in more than twenty years. The index rose over 10% during the streak. What’s going on?

The rally began after President Trump indicated a de-escalation of the trade war with China. There are ongoing negotiations with the other trading partners during the 90-day pause initiated on April 9^th. A perception is building that the worst of the tariff uncertainty is behind. Stocks also got a boost from earnings and economic news.

The market has leveled off since the huge recovery from the tariff Armageddon fears. And now, who knows.

The sticky issue to start the week is increasing trade tensions with China. A war of words is escalating between the two governments and threats are being made by both sides. It is being reported that President Trump will speak with Chinese President Xi today or later this week. Hopefully the two leaders will bring down the temperature.

Last week was another up week for the S&P 500. The index has made up all the losses since April and is now in positive territory for the year.

After a multi-month barrage of relentlessly negative headlines, the S&P is within 3% of the all-time high. Seven of the eleven market sectors are higher YTD, and two of the negative sectors are down less than 1% for the year so far.

Clean energy is the future. But not for a while.

This country and the world still rely heavily on fossil fuels for more than 80% of energy needs, and these conventional energy sources will likely remain dominant for decades. Meanwhile, many stocks of companies that benefit have strong earnings and great value.

Fossil fuel proportions are expected to move toward natural gas in the years ahead. A recent study estimates that global natural gas demand will soar 34% between 2022 and 2050 with the strongest growth in the natural gas realm to be liquid natural gas (LNG), with demand expected to more than double in the same time frame.

In this issue, I highlight one of the best natural gas companies on the market. It is a newly formed company in the business of exporting abundant and cheap American natural gas overseas. It’s big business. In a short time, this company has become one of the world’s largest natural gas exporters.

It’s been a great couple of weeks in the market, with the major indexes lifting nicely since the election and, more important, with leading growth stocks acting very well—while there have been some earnings wobbles, there’s been even more big rallies, with some stocks going into the stratosphere. It’s been a good couple of weeks, and with the evidence bullish, we are too—but we’re also keeping our feet on the ground, trimming some names on the way up and aiming to enter some fresher leaders, ideally on weakness.

While the outlook for 2025 is positive, things are changing.

Sure, this bull market has driven the S&P 500 nearly 70% higher. But most of the gains are from technology stocks. Until this past summer, nearly all the bull market returns were driven by technology. The rest of the market had done very little.

But the rest of the market is waking up. While artificial intelligence (AI) will likely continue to be a powerful growth catalyst, its dominance over everything else might not be as pronounced in 2025 as it has been in the past. Earnings for other stocks are catching up.

The earning growth difference between the “Magnificent 7” companies and the other 493 S&P 500 companies is expected to plummet from 27.8% last year to 8.3% this year. The rest of the market is cheap, has momentum, and will likely get hot this year as stocks experience an earnings growth spike that could last for years.

In this issue, I highlight a healthcare stock that looks highly promising in 2025. It is poised in front of the aging population megatrend, which makes a successful pick so much easier, and it will likely experience a sizable earning spike in the years ahead. It is an existing portfolio stock of which half the shares were sold last year. It’s a great time to buy back the other half.

The market sobered up in December after a big post-election rally in November. The S&P fell 2.5% in the last month of the year. But January has started out with stocks up 2.2% already.

Technology is driving the market higher. The sector is taking off after Nvidia (NVDA) issued bullish statements about demand for its artificial intelligence chips. AI is a huge growth catalyst for the market’s largest sector and has proven it can drive the indexes higher all by itself. In fact, technology has been the primary catalyst for the S&P over most of this bull market. But things might be changing.

AI is the catalyst driving the technology sector, which is driving the market higher. Over the last month, the tech sector is up 10.42% while the S&P is up 2.95%. Seven of the 11 sectors are negative for the past month.

But technology stocks may be running out of gas. Without the heavy lifting from technology, it’s easy to see the overall market trending sideways or down, at least for a while.

Income is king in markets like this. The register still rings when the market stumbles. There’s also an opportunity right now. With the S&P and many stocks near their 52-week highs, it’s a good time to get high call premiums. Also, you can lock in strong total returns from these stocks if they are called.

Even the best bull markets have ups and downs. We can play the increased likelihood of a flat or down market by priming the income pump to pay us through the rough patch. In this issue, I target another covered call that will enhance the already exquisite income of a monthly dividend stock.

The market remains a mixed bag, with some big-cap indexes moving up, but just about everything else still stuck in a trading range, while leading growth stocks remain hit or miss. That said, there are some encouraging signs, including some fresher leadership and resilient action among a bunch of names we’re watching and own, so we continue to play things in the middle--we’re holding some strong names and actually averaging up on one of our stocks tonight, but we’re also holding a chunk of cash and being selective.

We are in the early stages of a new cycle in the market.

The environment is changing from one of high inflation and high interest rates to one of falling inflation and interest rates in a weakening economy. And it is unlikely to be a mere short-term gyration but rather the beginning of a new environment that should last for some time.

Interest rates may fall quickly or more slowly depending on whether the economy remains buoyant or slips towards recession. But rates will fall much more significantly than they have in years.

The cycle reversal will create new winners and losers. Certain interest rate-sensitive stocks have been laggards for a long time and have a lot of catching up to do. They are still cheap, high yielding, and now have momentum.

In this issue, I highlight a great monthly income stock. The yield is massive, and it provides a high income in an uncertain market. The stock also can provide great price performance when the interest rate cycle goes its way. This point in the cycle provides a great opportunity to get a high income and total return on the right side of a pronounced market shift ahead.

The Fed’s moment has finally arrived.

The Fed raised the Fed Funds rate at the steepest pace since the 1980s in 2022 and 2023, from 0% to 5.5% over just an 18-month span. The Fed Funds rate has remained at a multi-decade high of 5.50% for more than a year. The Fed is expected to begin cutting the rate this week and will likely continue to do so for the next two years.

Spooky season is upon us! Yes, the usual October selling has commenced, although it’s been fairly mild thus far. But things feel unsettled, what with the expanding war in the Middle East, a toss-up presidential election less than a month away, and with earnings season getting underway this week. So today, to counter any further turbulence, we trim one modest laggard and add a new, low-beta, dividend-paying European stock that’s been a favorite of Cabot Explorer Chief Analyst Carl Delfeld for some time.

Details inside.

There is a colossal housing shortage in this country.

A decade of underbuilding in the housing industry following the financial crisis has left the industry unable to meet the needs of the growing population. It is estimated that the demand for homes exceeds the current national supply by a whopping 4.5 million.

The jilted supply/demand dynamic has caused the median U.S. home price to soar a staggering 40% just since the pandemic. In addition, mortgage rates have soared to the highest level in two decades. The prices and mortgage rates are making housing unaffordable for vast numbers of potential buyers. Sellers are unwilling to trade up and get a higher mortgage rate.

There aren’t enough new homes, and existing homes aren’t coming on the market either. Buyers can’t buy and sellers won’t sell. But there is reason to believe the housing problems will get a lot better in the years ahead.

While the situation is likely to improve, the supply/demand imbalance will likely remain for several years. That’s a problem for the housing market and economy to work through. But it’s good news if you’re a homebuilder. New homes should be in high demand for years to come, and sales should increase with the improving conditions.

In this issue, I highlight the premier luxury home builder in the U.S. The stock has the best track record of all large homebuilders, and the company is in an ideal position to benefit from high demand and increasing buying in the years ahead.

Selling accelerated this week after last week was the worst since September. The S&P is down 4% YTD and at its lowest level in more than five months. The Nasdaq index is in correction territory, down more than 10% from the high.

The big issue seems to be tariffs. Tariffs on China, Canada, and Mexico are escalating. The new Canadian Prime Minister also appears to be taking a hard line, and it looks like the trade issues won’t be resolved for a while. But it’s also the fact that tariffs are hitting the economy at a vulnerable point as fears of a slowing economy are growing.

After a strong start to the year, February was a down month for the S&P 500. The index is just a little over 1% higher YTD. But the news is better than it may seem.

Sure, the market has been struggling. But it’s only because of technology, which is down over 5% YTD. Nine of the other ten sectors in the S&P are positive for the year. Some sectors are having very good years as Health Care is up over 8% and Consumer Staples and Financials are up over 7% YTD.

More color on our recent sale that generated a 40% gain since September and comments on other recommended stocks.

Current Market Outlook


The major indexes continue to whip around, with last Monday’s dip followed by a strong recovery, and now a renewed drop. By our measures, the intermediate-term uptrend is on the fence, and it’s clear that large chunks of the broad market are falling apart (gold, silver and oil shares are especially weak). And, at the very least, it’s obvious the environment remains very choppy and making big money is difficult. Of course, we’ve seen repeated shakeouts followed by recoveries, but the evidence tells us to pull in our horns; we’re shifting the Market Monitor back toward neutral while we wait for the buyers to return.

When doing buying, the key is to focus on what’s working and this week’s list has a good batch to consider. Our Top Pick is Parexel (PRXL), a steady grower in the medical testing field that is just getting going after a couple of big corrections during the past year.

Stock Name	Price	Buy Range	Loss Limit
XPO Logistics (XPO)	0.00	36-38	33.5-34.5
Steel Dynamics (STLD)	0.00	23-24.5	21.5-22
Salix Pharmaceuticals (SLXP)	0.00	155-160	144-146
Charles Schwab (SCHW)	0.00	29-30	27.5-28
Parexel Corp. (PRXL)	0.00	59-61	55-56
Norwegian Cruise Lines (NCLH)	0.00	35.5-37	33.5-34
Gilead Sciences (GILD)	75.10	101-105	94-96
Canadian Solar (CSIQ)	0.00	35.5-37	32.5-33
Spansion (CODE)	0.00	22-23	20.5-21
Archer Daniels (ADM)	0.00	50-51	47-48

The Cabot Undervalued Stocks Advisor is on vacation this week, recharging the batteries for what could be a very interesting September and fourth quarter in the financial markets. As such, this week’s edition will be abbreviated in length, although we include our Cisco earnings commentary in full.

The trend is still up, and we’re leaving our Market Monitor in bullish territory because the odds continue to favor higher prices in the weeks and months ahead. However, for the first time this year, we are starting to see a few chinks in the armor—volume is picking up a bit on the down days, growth stocks are lagging while some defensive-type sectors are pushing ahead, and we’re seeing some choppy up-and-down action. As we wrote in Friday’s update, none of these are “get out now” signs, but lightening up or selling your laggards makes sense. And, going ahead, should the market get rougher, you’ll find added value from our new Suggested Stop-Loss levels, which we include on every recommendation.

This week’s list has an encouragingly strong group of quality growth stories and charts. Our favorite of the week is RockTenn (RKT), a containerboard company that few investors are giddy about. But earnings growth will be big going ahead, and the stock is closing in on a good buy point.

Stock Name	Price	Buy Range	Loss Limit
United Continental Holdings (UAL)	96.76	30.5-31.5	27.5-28.5
Tenet Healthcare (THC)	0.00	44.5-46	40.5-41.5
Splunk (SPLK)	207.67	36-38	33-35
Shutterfly (SFLY)	94.71	41-43	38.5-39.5
Range Resources (RRC)	0.00	78-81	72-73
Rockwood Holdings (ROC)	0.00	63-65	57-59
RockTenn (RKT)	0.00	85-87.5	82.5-83
Meritage Homes (MTH)	102.20	45-47	41-42
FleetCor Technologies (FLT)	0.00	72-75	65-67
HomeAway, Inc. (AWAY)	0.00	30-32	27-28

The U.S. stock market rebounded on Tuesday, following testimony from Chair Powell at his Senate confirmation hearing. Investors liked what he said, implying that the three anticipated quarter-point rate increases, which could start in March, would likely be enough to quell inflation (along with a hoped-for return to normal supply conditions).